Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
Haley Sipes lost 75 pounds over 10 months with diet and exercise alone. On TikTok, where the 31-year-old mother of three chronicled her weight loss journey, commenters speculated that she was using ...
Rising consumer demand for fewer empty calories is pushing the snack and beverage giant to offer options with less sodium, ...
Last year, my economists at the U.S. Congress Joint Economic Committee told an uncomfortable truth: Our poor health is not ...
Diagnoses have been rising for decades but seem to have accelerated in the last few years ... professionals who treat adults, and expects to release them later this year. The goal is “to ...
Meanwhile, Eli Lilly’s stocks dipped ... of last year, the Danish pharmaceutical company experienced a 21% plunge in its share price following disappointing trial results for its new obesity ...
Novo Nordisk (NVO) shares traded sharply higher in European trading on Friday after the Danish drugmaker said amycretin, one of its novel obesity therapies, caused up to 22% of weight loss over 36 ...
A 14-year-old male ... left a woman dead last year. The Delaware County Prosecutor’s Office announced Wednesday that Cameron Drummer has been preliminarily charged as an adult for his alleged ...
Flu activity has seen a small dip this week ... A being more aggressive in adults. However, Flu B has the potential to see increases later in the season. Last year, the flu season was categorized ...
Many analysts thought it would surpass $1 trillion in valuation last year but that didn’t happen ... so I think buying the dip can be a good idea. Troubling, but unlikely to be a key factor ...
Weight-loss drugs are probably playing a part in the slight dip in obesity in the US. But like many other parts of the world, the country has seen high inflation during the past few years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results